Precision Neuroscience

Precision Neuroscience is a medical technology company based in Manhattan, New York, founded in 2021. The company specializes in developing advanced brain-computer interface (BCI) systems aimed at restoring communication and independence for individuals with severe neurological conditions, particularly paralysis. Their flagship product, the Layer 7 Cortical Interface, is a high-resolution cortical surface array that records brain signals using thin-film electrodes placed on the brain's surface, minimizing damage. The Layer 7 Cortical Interface translates neural activity into digital commands, allowing users to control digital devices through thought alone. The processing unit is implanted between the skull and scalp, facilitating communication with connected devices. Precision Neuroscience is focused on clinical applications that enhance the independence of severely paralyzed individuals and is also exploring uses in stroke rehabilitation and treatment of refractory depression. The company collaborates with leading medical centers to conduct clinical trials and has developed its own manufacturing facility for the Layer 7 Cortical Interface.

• Employees110
• Founded2021
• Annual Revenue$5500000
• Total Funding$275768938